Posts In: Gubba Pharma In E News

US FDA chief’s exit could impact Indian pharma

March 28, 2019 Gubba Pharma In E News

The abrupt exit of the US FDA commissioner Scott Gottlieb after a nearly 2-year stint under the Trump administration throws Indian pharma into uncertainty on...

Continue Reading

India gets tough on generics quality issues and cancer drug prices

March 28, 2019 Gubba Pharma In E News

Even as more blood pressure drugs are being recalled in the USA after being found to contain trace amounts of a potentially cancer-causing ingredient, India’s...

Continue Reading

Suven plans to buy US-based Rising Pharmaceuticals’ assets

March 28, 2019 Gubba Pharma In E News

Suven Life Sciences through its joint venture partner, Shore Suven Pharma, has entered into a ‘stalking-horse’ asset purchase agreement to buy the assets of Aceto...

Continue Reading

USFDA lifts warning letter on Dr Reddy’s Duvvada plant in Andhra Pradesh

March 28, 2019 Gubba Pharma In E News

This is the second plant to come out of the warning letter after multiple inspections conducted by the US drug regulator. In a major relief to...

Continue Reading

Big relief for cancer patients: 30% margin on medicines to reduce prices, benefit poor

March 28, 2019 Gubba Pharma In E News

The healthcare industry has hailed the Modi government for capping 30 per cent margin on 42 drugs meant for the cancer patients. The industry insiders...

Continue Reading

Industry, regulator interaction needed for clarification on BA/BE submission norms

March 28, 2019 Gubba Pharma In E News

Even as the Central Drugs Standards Control Organisation (CDSCO) has set the ball rolling for BA/BE (bioavailability/ bioequivalence) submissions, the pharma and biotech industry in...

Continue Reading

Slayback Pharma announces approval of Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 mL in a single-dose vial, generic equivalent of Makena® Injection 250 mg/ 1 mL

March 28, 2019 Gubba Pharma In E News

Slayback Pharma LLC announced today that it has received final approval for Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 ml. This is the second ANDA...

Continue Reading


Plot no-118-A, Five Star Industrial Area, MIDC, Shendra, Aurangabad.


Survey No.271,Muppireddypalli (Village),Toopran Mandal, Medak District, Hyderabad,Telangana


Survey No.255, Kandlakoya Village, Medchal R R Dist, Hyderabad,Telangana


Plot No. 101 & 103 IDA Medchal R R District, Hyderabad,Telangana


Plot No. 101 & 103 IDA Medchal R R District, Hyderabad,Telangana

Survey No. 46, Mediciti Hospital, Rajbollaram (village),Medchal R R Dist, Hyderabad,Telangana

Survey No.741 Lalgadi Malakpet VillageShameerpet Mandal, R R Dist, Hyderabad,Telangana

Plot : C-8/2a, Industrial Area, Uppal, Hyderabad,Telangana

Plot No.1, Survey No.85/A, Yellampet, Medchal R R Dist, Hyderabad,Telangana

Plot No.2 Survey No.85/A, Yellampet, Medchal R R Dist, Hyderabad,Telangana

Survey No.150&151, Athavelli village, Medchal R R Dist, Hyderabad,Telangana

Survey No.150&151, Athavelli village, Medchal R R Dist, Hyderabad,Telangana

Survey No : 84 C & G, Yellampet Village, Medchal Mandal, R.R Dist, Hyderabad,Telangana


MCJR+C4 Nutankal, Telangana


Banda Mailaram, Telangana 502336


Plot : C-8/2a, Industrial Area, Uppal, Hyderabad,Telangana


Aanaram, Telangana 500043


Kothur Village, Telangana 502279


Visakhapatnam, Andhra Pradesh 530012


Surat, Gujarat 396430


Gundlapochampally, Telangana 500014


MEDCHAL, NEAR ELECTRICAL OFFICE, 501401 R R DIST. Hyderabad


Hyderabad, Telangana 501401


Siddipet, Telangana 502279


Medchal Mandal, Hyderabad, Telangana 501401


Nizamabad, Telangana 503230


IDA, Medchal, 501401